Osborne Clarke steers Grifols´ acquisition of seven plasma centres

Osborne Clarke has advised Spain´s Grifols on its acquisition of seven plasma centres in the US as part of its expansion plan

Grifols, a global leader in the development of plasma-derived medicines with a track record of more than 100 years dedicated to enhancing people’s health and well-being, closed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory clearances and will be financed with Grifols’ own resources, without issuing debt.

Grifols will gain immediate access to the plasma obtained in these centres, which obtain approximately 240,000 litres per year. The seven newly acquired centres are authorized by the U.S. Food and Drug Administration (FDA) and European healthcare authorities.

This acquisition reflects Grifols’ commitment to enlarge its plasma supply through organic and inorganic growth.

Since January 2021, Grifols’ efforts to accelerate the execution of its strategic expansion plan have enabled it to instantly leverage approximately 1.4 million more litres of plasma yearly. At the same time, the company continues its efforts to open new centres.

This most recent acquisition advances Grifols’ strategy to reinforce and diversify its access to plasma. An industry leader, the company boasts a robust network of 351 plasma centres, with 296 in the United States and 55 in Europe across Germany, Austria and, recently Hungary.
The transaction reinforces the company’s efforts to strengthen its plasma centre network, which represents a significant competitive advantage. Grifols remains committed to increasing the availability of its life-enhancing plasma-derived products for patients who need them and doing its utmost to respond to expected strong demand.

Grifols retained the legal services of Osborne Clarke S.L.P. for this deal, advising with a team formed by founding partner Tomás Dagá (pictured left), Commercial & Corporate partner Oscar Calsamiglia (pictured centre) and Commercial & Corporate lawyer Ignasi Bruguer (pictured right).

Desire Vidal